Optimization of Cardiac Imaging in Women With Early-Stage Breast Cancer
for
Breast Cancer With Low to Intermediate HER2 Expression
Location: Rochester NY
Sponsor: University of Rochester
Sex: Female
Age: 18 - 70+
Code: NCT07630402
Recruiting
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
for
PIK3CA Mutations, Advanced Solid Tumors, Adult,
Location: Boston MA, East Brunswick NJ, Fairfax VA, Tampa FL,
Sponsor: Cogent Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT07383506
Phase1, Recruiting
Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy
for
Locally Advanced Cancer, Metastatic Cancer, HER2,
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center
Sex: All
Age: 18+
Code: NCT06828588
Early_phase1, Recruiting
ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer
for
Metastatic Breast Cancer, HER2 Low Breast Carcinoma,
Location: Boston MA
Sponsor: Kristina A. Fanucci
Sex: All
Age: 18+
Code: NCT07198724
Phase1, Phase2, Recruiting
HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)
Location: Boston MA, Philadelphia PA, Rochester NY, Durham NC,
Sponsor: NICHD Neonatal Research Network
Sex: All
Age: 0
Code: NCT06676904
Recruiting
Atlantic Lipid Lowering Treatment Optimization Program
for
Familial Hypercholesterolemia,
Location: Springfield NJ
Sponsor: Atlantic Health System
Sex: All
Age: 18 - 70+
Code: NCT06439654
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
for
Breast Neoplasms, Triple Negative Breast Neoplasms,
Location: St. John's, Westbrook ME, Boston MA, Quebec, Sherbrooke,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06966700
Phase3, Recruiting
Safety of MT-401-OTS in Patients With Relapsed AML or MDS
for
Acute Myeloid Leukemia, in Relapse, MDS
Location: Tampa FL, Kansas City KS, Duarte CA
Sponsor: Marker Therapeutics, Inc.
Sex: All
Age: 65+
Code: NCT06552416
Phase1, Recruiting
Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies
for
Relapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDS,
Location: Baltimore MD, Washington D.C. DC
Sponsor: Catherine Bollard
Sex: All
Age: 0 - 70+
Code: NCT02203903
Phase1, Recruiting
New
Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome